European Union reviews J&J clot link, widens AstraZeneca probe

European Union reviews J&J clot link, widens AstraZeneca probe

By AFP PARIS: Europe’s stuttering vaccine rollout faced multiple shocks on Friday as EU regulators said they were reviewing side effects of the Johnson & Johnson shot and France further limited its use of the AstraZeneca jab. Much of the world is still in the clutches of the pandemic that has killed 2.9 million people — from Brazil, where the virus is killing more than 4,000 people a day — to Japan where the government has tightened restrictions once again. India is also suffering, and hotspot Maharashtra state is running…

Read More

AstraZeneca: Who is using the anti-COVID jab, and who is not

AstraZeneca: Who is using the anti-COVID jab, and who is not

By AFP The AstraZeneca vaccine’s rollercoaster ride has taken another twist with a growing list of countries restricting its use over “very rare” blood clots. While Britain, whose Oxford University developed it, now no longer recommends it for the under 30s, South Africa has rejected it outright.   Nevertheless, the vaccine is still the most widely used in the world and remains cheaper and easier to store than its competitors.  It has already been given in some 111 countries — more than its competitors Pfizer/BioNTech and Moderna put together —…

Read More

Australia halts AstraZeneca shots for under 50s over clot concerns

Australia halts AstraZeneca shots for under 50s over clot concerns

By AFP SYDNEY: Australia on Thursday joined a growing number of countries halting the use of the AstraZeneca coronavirus vaccine for younger people over fears it can cause serious blood clots. In a further setback for Australia’s already halting coronavirus vaccine rollout, officials said the AstraZeneca shot should no longer be given to people under the age of 50, unless they had already received a first dose without any ill effects. Prime Minister Scott Morrison held an evening press conference to announce the decision shortly after the government’s medical advisory…

Read More

EU drug regulator confirms AstraZeneca blood clot link but says COVID jab still safe

EU drug regulator confirms AstraZeneca blood clot link but says COVID jab still safe

By AFP HAGUE: The EU’s drug regulator said Wednesday that blood clots should be listed as a “very rare” side effect of the AstraZeneca coronavirus vaccine but that the jab’s benefits continue to outweigh the risks. No specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune response, the European Medicines Agency (EMA) said. But the watchdog faced questions about its findings as several European countries have discouraged the use of the vaccine in younger people due to the clots,…

Read More

European regulator to explain link between AstraZeneca COVID vaccine and blood clot

European regulator to explain link between AstraZeneca COVID vaccine and blood clot

By Associated Press LONDON: The European Medicines Agency will announce the conclusions of its investigation into the possible connection between AstraZeneca’s coronavirus vaccine and rare blood clots later Wednesday. On Tuesday, a senior EMA official said there was a causal link between the AstraZeneca vaccine and the rare blood clots that have been seen in dozens of people worldwide, among the tens of millions who have received at least one dose. In comments to Rome’s Il Messaggero newspaper, Marco Cavaleri, head of health threats and vaccine strategy at the Amsterdam-based agency,…

Read More

AstraZeneca UK vaccine trial in children paused as clot link probed

AstraZeneca UK vaccine trial in children paused as clot link probed

By AFP A British trial of the AstraZeneca coronavirus vaccine on children has been paused, Oxford University said Tuesday, as global regulators rush to assess its possible link to rare blood clots in adults. The university, which helped develop the embattled vaccine, said in a statement that there were “no safety concerns” in the trial, but acknowledged fears over a potential link to clots by saying that it was awaiting additional data from Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) before restarting the study. “Parents and children should continue to attend…

Read More

EU medicines regulator approves new vaccine production sites

EU medicines regulator approves new vaccine production sites

By Associated Press LONDON: The European Union’s medicines regulator on Friday said it has approved new manufacturing sites for coronavirus vaccines made by Pfizer-BioNTech, Moderna and AstraZeneca, in a move that could significantly boost Europe’s supply of the shots and speed vaccination efforts across the continent. The European Medicines Agency said in a statement that it had approved sites in the Netherlands, Germany and Switzerland for the COVID-19 vaccines made by the companies. The new approvals come amid the 27-nation bloc’s struggles to ramp up COVID-19 vaccination and repeated delivery…

Read More

Pfizer joins Moderna, AstraZeneca in conducting COVID vaccine trial on children

Pfizer joins Moderna, AstraZeneca in conducting COVID vaccine trial on children

By AFP WASHINGTON: Pfizer said Thursday it had begun clinical trials for its Covid vaccine in children under the age of eleven, an early sign of the next stage of the global immunization campaign. “Together with our partner BioNTech, we have dosed the first healthy children in a global Phase 1/2/3 continuous study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine,” the company said in a statement to AFP. “We are proud to start this much needed study for children and families eagerly awaiting a possible vaccine option.” According to details posted on the site clinicaltrials.gov, the company is testing three…

Read More

Denmark prolongs suspension of AstraZeneca COVID-19 vaccine

Denmark prolongs suspension of AstraZeneca COVID-19 vaccine

By Associated Press COPENHAGEN: The Danish government decided Thursday to continue its suspension of the AstraZeneca COVID-19 for three more weeks. Denmark paused the use of the AstraZeneca as a precautionary measure on March 11 after reports that a 60-year-old woman died with blood clots in several parts of her body a week after she received the vaccine, according to health officials. The death of a second person in Denmark who died after getting the AstraZeneca vaccine was reported shortly after. Danish health authorities said they have no evidence the…

Read More